PARP1 and B-cell non-Hodgkin lymphoma: Furthermore, genes like CDK7 (Zhao et al. 2019), NRF2 (Sanghvi et al. 2021), and PARP1 (Parvin et al. 2019) are established chemoresistance markers for various therapies in B-cell lymphoma.